CMECNECPECDR

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

This activity is supported by educational funding provided by Amgen and Sanofi US and Regeneron Pharmaceuticals.

Overview

Author(s)/Faculty: Joyce L. Ross, MSN, ANP, CRNP, CLS, FNLA; Dave L. Dixon, PharmD, BCPS, CDE, FNLA; Dean A. Bramlet, MD, FNLA; Daniel J. Rader, MD, FNLA; Joseph J. Saseen, PharmD, CLS, FNLA
Source: Healio - Cardiology Education Lab
Type: LectureArticles/Items: 4
Release Date: 8/11/2017Expiration Date: 8/11/2018
Credit Type: CDR / CME / CNE / CPENumber of Credits: 2
Cost: FreeProvider: National Lipid Association

With each passing year we gain new insight and understanding around the clinical utilization of lipid-lowering therapeutic agents. Our historical experience with older agents can often inform our knowledge and interpretation of how we view newly available options and those in development.

How does our prior experience with statins and LDL-C lowering help us to better utilize and contextualize the newest classes of specialized high-intensity therapies? When do we consider off-label drug use in patient populations without outcomes data? Where is the future of individualized risk management headed? These are the some of the questions our expert-presenters addressed with a live audience in Philadelphia.

Join us on Cardiology Today’s Healio.com to view the interactive session and earn free CME/CE credits.

CE Information

page 1 of 7